{"id":"52f32f0a-f98b-52f6-a42a-562e0540a39b","stable_key":"09b23d0d-35e2-51ff-b1aa-b4f9227e4fa2:isoleucine-phenylbutyrate-plasma","predicate":"reduces_tested","statement":"Sodium phenylbutyrate-treated urea-cycle-disorder patients had lower circulating BCAAs despite adequate protein intake; low steady-state BCAAs were also observed in treated controls.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"072d48d0-3251-5e7c-91e8-789d94a5c4cd","mechanism_event_label":"A low amino-acid pool can reflect drug-related handling, not just low intake.","subject":{"id":"59e582c7-8a5b-5bc0-900d-42eb6c0e30be","slug":"sodium-phenylbutyrate","display_name":"Sodium phenylbutyrate","entity_type_key":"drug"},"object":{"id":"9a0e9043-4d53-5374-ad2e-832ebf4cf1dc","slug":"human-phenylbutyrate-bcaa-pool","display_name":"Circulating BCAAs during sodium phenylbutyrate exposure","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"072d48d0-3251-5e7c-91e8-789d94a5c4cd","stable_key":"09b23d0d-35e2-51ff-b1aa-b4f9227e4fa2:isoleucine-phenylbutyrate-plasma-event","event_type":"observed_relationship","label":"A low amino-acid pool can reflect drug-related handling, not just low intake.","description":"Sodium phenylbutyrate-treated urea-cycle-disorder patients had lower circulating BCAAs despite adequate protein intake; low steady-state BCAAs were also observed in treated controls.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"59e582c7-8a5b-5bc0-900d-42eb6c0e30be","slug":"sodium-phenylbutyrate","display_name":"Sodium phenylbutyrate","entity_type_key":"drug"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"9a0e9043-4d53-5374-ad2e-832ebf4cf1dc","slug":"human-phenylbutyrate-bcaa-pool","display_name":"Circulating BCAAs during sodium phenylbutyrate exposure","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"c85b327e-f132-5d9a-8e4b-c2976fcc0373","slug":"isoleucine","display_name":"L-Isoleucine","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"f707c753-cc8c-5f06-90be-bb3d73c60a18","slug":"leucine","display_name":"L-Leucine","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"ae40617e-3df7-5d48-8dd2-f16a0d3a8a25","slug":"valine","display_name":"L-Valine","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""},{"entity":{"id":"8637bb39-2c30-5168-baaf-3e613d831db0","slug":"glutamine","display_name":"L-Glutamine","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":5,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"biomarker_context","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_access","value_text":"Primary abstract","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Human stable-isotope-study sampling and treated control comparisons.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Mixed BCAA effect; dietary decisions in urea-cycle disorders require the full clinical context.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"L-Isoleucine collection; species, compartment, exposure, co-substrates and manipulation remain explicit.","comparator":null,"unit":null,"notes":"","entity":{"slug":"isoleucine","display_name":"L-Isoleucine","entity_type_key":"small_molecule"}},{"dimension":"plain_language","value_text":"A low amino-acid pool can reflect drug-related handling, not just low intake.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"New insights in nutritional management and amino acid supplementation in urea cycle disorders. · 2010 · https://pubmed.ncbi.nlm.nih.gov/20299258/ · DOI 10.1016/j.ymgme.2010.02.019","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"biomarker_context","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"3e0a59a8-c86b-57d4-a2ba-75fd4f45265f","evidence_kind":"source_excerpt","locator":"Lines 306-312","start_line":306,"end_line":312,"excerpt":"## isoleucine-phenylbutyrate-plasma\nA low amino-acid pool can reflect drug-related handling, not just low intake.\nSodium phenylbutyrate-treated urea-cycle-disorder patients had lower circulating BCAAs despite adequate protein intake; low steady-state BCAAs were also observed in treated controls.\nModel: Human stable-isotope-study sampling and treated control comparisons.\nLimitations: Mixed BCAA effect; dietary decisions in urea-cycle disorders require the full clinical context.\nEvidence access: Primary abstract\nNew insights in nutritional management and amino acid supplementation in urea cycle disorders. · 2010 · https://pubmed.ncbi.nlm.nih.gov/20299258/ · DOI 10.1016/j.ymgme.2010.02.019","model_system":"Human stable-isotope-study sampling and treated control comparisons.","directness":"reported_statement","verification_status":"source_derived_draft","notes":"Original curation paraphrase; evidence access and experimental limitations specified.","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"4b00f118-00fd-5cef-be97-13125eb958e9","stable_key":"import-09b23d0d-35e2-51ff-b1aa-b4f9227e4fa2","title":"L-Isoleucine: transport, translation, catabolism and cross-nutrient mechanisms (2026-09-19)","document_type":"imported_text","citation_label":"AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text.","file_path":"","sha256":"2058ff0da379586994e7fda6ae0086c60fa3173542bfaf1fb3871ad3e09f9c6c","revision_id":"f32192d4-9913-5d35-acbc-cf90ff17995e","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}